American Heart Association
Shifting Paradigms in Lipid Management for ASCVD Risk
Main Event
Main Event 2
Nov 8th , 01:30 PM - 02:45 PM
01 : 30 PM
Efficacy and Safety of Enlicitide, an Oral PCSK9 Inhibitor, for Lowering LDL Cholesterol in Adults with or At-Risk for ASCVD: The Phase 3 CORALreef Lipids Trial
Navar Ann Marie, Mendizabal Geraldine, Nuez Llota Julio, Zhu Pengfei, Zhuo Min, Ballantyne Christie, Mikhailova Elina, Catapano Alberico, Banka Puja, Blom Dirk, Cadena Alberto, Kourpanidis Susan, Lepor Norman, Tsukamoto Kazuhisa
Final Pr. ID: -
Authors: Navar Ann Marie, Mendizabal Geraldine, Nuez Llota Julio, Zhu Pengfei, Zhuo Min, Ballantyne Christie, Mikhailova Elina, Catapano Alberico, Banka Puja, Blom Dirk, Cadena Alberto, Kourpanidis Susan, Lepor Norman, Tsukamoto Kazuhisa
Keywords: PCSK9 , LDL , Atherosclerosis , Hyperlipidemia , Cardiovascular disease prevention
Lloyd-jones Donald
Final Pr. ID: -
Authors: Lloyd-jones Donald
Grant Jelani
Final Pr. ID: -
Authors: Grant Jelani
01 : 46 PM
Lower LDL-C, for Longer? Defining the Optimal Timing and Intensity of Lipid-Lowering Therapy in Primary Prevention
Blumenthal Roger
Final Pr. ID: -
Authors: Blumenthal Roger
01 : 54 PM
The ODYSSEY of Lipid Lowering: Navigating the Growing Array of Therapeutics for LDL-C Reduction
Tokgozoglu Lale
Final Pr. ID: -
Authors: Tokgozoglu Lale
O'donoghue Michelle
Final Pr. ID: -
Authors: O'donoghue Michelle
Orringer Carl
Final Pr. ID: -
Authors: Orringer Carl
Musunuru Kiran
Final Pr. ID: -
Authors: Musunuru Kiran
Orringer Carl
Final Pr. ID: -
Authors: Orringer Carl
Grant Jelani
Final Pr. ID: -
Authors: Grant Jelani
Lloyd-jones Donald
Final Pr. ID: -
Authors: Lloyd-jones Donald
01 : 30 PM
Efficacy and Safety of Enlicitide, an Oral PCSK9 Inhibitor, for Lowering LDL Cholesterol in Adults with or At-Risk for ASCVD: The Phase 3 CORALreef Lipids Trial
Navar Ann Marie, Mendizabal Geraldine, Nuez Llota Julio, Zhu Pengfei, Zhuo Min, Ballantyne Christie, Mikhailova Elina, Catapano Alberico, Banka Puja, Blom Dirk, Cadena Alberto, Kourpanidis Susan, Lepor Norman, Tsukamoto Kazuhisa
Final Pr. ID: -
Authors: Navar Ann Marie, Mendizabal Geraldine, Nuez Llota Julio, Zhu Pengfei, Zhuo Min, Ballantyne Christie, Mikhailova Elina, Catapano Alberico, Banka Puja, Blom Dirk, Cadena Alberto, Kourpanidis Susan, Lepor Norman, Tsukamoto Kazuhisa
Keywords: PCSK9 , LDL , Atherosclerosis , Hyperlipidemia , Cardiovascular disease prevention
Musunuru Kiran
Final Pr. ID: -
Authors: Musunuru Kiran
01 : 46 PM
Lower LDL-C, for Longer? Defining the Optimal Timing and Intensity of Lipid-Lowering Therapy in Primary Prevention
Blumenthal Roger
Final Pr. ID: -
Authors: Blumenthal Roger
O'donoghue Michelle
Final Pr. ID: -
Authors: O'donoghue Michelle
01 : 54 PM
The ODYSSEY of Lipid Lowering: Navigating the Growing Array of Therapeutics for LDL-C Reduction
Tokgozoglu Lale
Final Pr. ID: -
Authors: Tokgozoglu Lale